Pregabalin - NDC Database (Page 19)

685 records found
Page:First PagePrevious Page19Next PageLast Page
70518-2290 Aug 30, 2019
Pregabalin 225 mg Oral Capsule by Remedyrepack Inc.
70518-2364 Oct 16, 2019
Pregabalin 100 mg Oral Capsule by Remedyrepack Inc.
70518-2483 Dec 13, 2019
Pregabalin 150 mg Oral Capsule by Remedyrepack Inc.
70518-2525 Jan 06, 2020
Pregabalin 75 mg Oral Capsule by Remedyrepack Inc.
70518-2568 Feb 05, 2020
Pregabalin 150 mg Oral Capsule by Remedyrepack Inc.
70518-2569 Feb 06, 2020
Pregabalin 225 mg Oral Capsule by Remedyrepack Inc.
70518-2571 Feb 07, 2020
Pregabalin 50 mg Oral Capsule by Remedyrepack Inc.
70518-2689 Apr 14, 2020
Pregabalin 25 mg Oral Capsule by Remedyrepack Inc.
70518-2745 May 14, 2020
Pregabalin 100 mg Oral Capsule by Remedyrepack Inc.
70518-2762 Jun 03, 2020
Pregabalin 50 mg Oral Capsule by Remedyrepack Inc.
70518-2763 Jun 04, 2020
Pregabalin 200 mg Oral Capsule by Remedyrepack Inc.
70518-2892 Sep 18, 2020
Pregabalin 150 mg Oral Capsule by Remedyrepack Inc.
70518-2948 Nov 27, 2020
Pregabalin 75 mg Oral Capsule by Remedyrepack Inc.
70518-2978 Dec 28, 2020
Pregabalin 300 mg Oral Capsule by Remedyrepack Inc.
70518-2980 Jan 06, 2021
Pregabalin 225 mg Oral Capsule by Remedyrepack Inc.
70518-3345 Jan 27, 2022
Pregabalin 150 mg Oral Capsule by Remedyrepack Inc.
70518-3346 Jan 27, 2022
Pregabalin 300 mg Oral Capsule by Remedyrepack Inc.
70518-3597 Dec 21, 2022
Pregabalin 75 mg Oral Capsule by Remedyrepack Inc.
70518-3636 Feb 09, 2023
Pregabalin 50 mg Oral Capsule by Remedyrepack Inc.
70518-3642 Feb 15, 2023
Pregabalin 225 mg Oral Capsule by Remedyrepack Inc.
Page:First PagePrevious Page19Next PageLast Page
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.